Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases
Open Access
- 15 June 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 13 (16) , 1803-1813
Abstract
Polyglutamine diseases are characterized by neuronal intranuclear inclusions (NIIs) of expanded polyglutamine proteins, indicating the failure of protein degradation. UBB+1, an aberrant form of ubiquitin, is a substrate and inhibitor of the proteasome, and was previously reported to accumulate in Alzheimer disease and other tauopathies. Here, we show accumulation of UBB+1 in the NIIs and the cytoplasm of neurons in Huntington disease and spinocerebellar ataxia type-3, indicating inhibition of the proteasome by polyglutamine proteins in human brain. We found that UBB+1 not only increased aggregate formation of expanded polyglutamines in neuronally differentiated cell lines, but also had a synergistic effect on apoptotic cell death due to expanded polyglutamine proteins. These findings implicate UBB+1 as an aggravating factor in polyglutamine-induced neurodegeneration, and clearly identify an important role for the ubiquitin–proteasome system in polyglutamine diseases.Keywords
This publication has 42 references indexed in Scilit:
- Impairment of proteasome structure and function in agingThe International Journal of Biochemistry & Cell Biology, 2002
- Brain proteasomal function in sporadic Parkinson's disease and related disordersAnnals of Neurology, 2002
- Protein surveillance machinery in brains with spinocerebellar ataxia type 3: Redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusionsAnnals of Neurology, 2002
- Differential susceptibility of cultured cell lines to aggregate formation and cell death produced by the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretchBrain Research Bulletin, 2001
- Mutation of the E6-AP Ubiquitin Ligase Reduces Nuclear Inclusion Frequency While Accelerating Polyglutamine-Induced Pathology in SCA1 MiceNeuron, 1999
- The Length of Polyglutamine Tract, Its Level of Expression, the Rate of Degradation, and the Transglutaminase Activity Influence the Formation of Intracellular AggregatesBiochemical and Biophysical Research Communications, 1999
- Huntington's Disease Intranuclear Inclusions Contain Truncated, Ubiquitinated Huntingtin ProteinExperimental Neurology, 1999
- Regional Specificity of Brain Atrophy in Huntington's DiseaseExperimental Neurology, 1998
- Intranuclear Inclusions of Expanded Polyglutamine Protein in Spinocerebellar Ataxia Type 3Neuron, 1997
- Machado‐Joseph disease gene product is a cytoplasmic protein widely expressed in brainAnnals of Neurology, 1997